Institutional Holdings and Trade Data for Depomed, Inc. (DEPO)

In the past 52-week period, shares of Depomed, Inc. (NASDAQ:DEPO) have moved within the range of $4.31 to $21.38. On the stock’s most recent trading day, the company’s shares ended the regular session at $8.17, which is 61.79% higher than its 52-week high.

Depomed, Inc. (DEPO) has demonstrated a 20-day simple moving average (SMA) of 22.84%, and a 50-day SMA of 39.43%. This public company’s current market capitalization stands at $514.69 million.

Analyzing Consensus Estimates, Sales Revenue and Net Income

Understanding Wall Street analyst’s enthusiasm for a particular stock is crucial when considering entering a position. According to the latest data, the consensus recommendation for Depomed, Inc. (DEPO) is Hold.

When it comes to sales data, public companies usually post revenue and earnings that are either higher or lower than the average Wall Street forecast. In the most recent quarterly financial report, for the quarter ending Sep. 2017, Depomed, Inc. (DEPO) delivered a 3.77% surprise with its net revenue. Sales reached $0.1 billion during the three-month period, compared to the average analyst estimate of $0.1 billion.

Meanwhile, during the same quarter Depomed, Inc. (DEPO) delivered a 32.45% earnings surprise. Net earnings for the quarter were posted at $0.14 per share, whereas Wall Street had forecast $0.11 per share.

Ownership at Depomed, Inc. (DEPO), According to Most Recent SEC Filings

A public company’s latest 13F filings tell investors important details about institutional ownership. Depomed, Inc. (DEPO) has 0 billion shares outstanding currently, 92.11% of which belong to institutional investors. Those institutional holdings amount to $0.47 billion.

Additionally, according to the most recent 13F filing from Depomed, Inc. (DEPO), there were 19 new positions totaling 1,306,299 shares of the company’s stock. There were 28 sold out positions, on the other hand, totaling 5,594,612 shares.

Short, Medium and Long Term Indicators

Examining a stock’s average volume in the short, medium and long term is useful to understand trading activity and investor sentiment. Depomed, Inc. (DEPO) has had a 20-day average volume of 1,934,505 shares, with an average of 80% of short term indicators pointed at Buy.

The stock’s 50-day average volume has been 1,701,586 shares, with an average of 100% of medium term indicators pointing toward Buy. Finally, its 100-day average volume is 1,720,904 shares with 33% of long-term indicators pointing to Buy.